Sinnreich Matthew Phillip 4
4 · Organicell Regenerative Medicine, Inc. · Filed Oct 17, 2022
Insider Transaction Report
Form 4
Sinnreich Matthew Phillip
DirectorPresident and Acting CEO
Transactions
- Sale
Common Stock, $0.001 par value
2022-10-13$0.04/sh−20,000$800→ 6,976,000 total(indirect: See Footnote)
Footnotes (1)
- [F1]Represents shares of common stock held by Retrograde Investments, LLC, in which entity the Reporting Person is a minority holder and over which the Reporting Person has shared voting and dispositive power.